IP Library Granted Patent US 10,189,878
Granted Patent B2
US 10,189,878 · App. 15/513,959 · Granted Jan 29, 2019

Ebolavirus pre-hairpin intermediate mimics and methods of use

Inventors: Tracy R. Clinton (Charlottesville, VA); Michael Thomas Jacobsen (Salt Lake City, UT); Matthew T. Weinstock (San Diego, CA); Brett D. Welch (Salt Lake City, UT); Debra Muir Eckert (Salt Lake City, UT); Michael S. Kay (Salt Lake City, UT)
Assignees: University of Utah Research Foundation; Navigen, Inc.; The United States of America—Air Force
C07K14/005C07K14/08G01N33/6845A61K38/00C12N2760/14122C12N2760/14133G01N2333/08G01N2500/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,189,878
App. No.
15/513,959
Granted
Jan 29, 2019
Kind
B2
Abstract

Ebolavirus is a highly lethal filovirus that causes hemorrhagic fever in humans and non-human primates. With no approved treatments or preventatives, the development of an anti- ebolavirus therapy to protect against natural infections and potential weaponization is an urgent unmet global health need. The design, biophysical characterization, and validation of peptide mimics of the ebolavirus N-trimer (“N-trimer mimics”) are described herein.

Claims (6)

1. An Ebolavirus N-trimer mimic comprising a homotrimer of peptide monomers, wherein each peptide monomer comprises an an amino acid sequence of SEQ ID NO:23 or SEQ ID NO:21.

2. The Ebolavirus N-trimer mimic of claim 1 , wherein each peptide monomer comprises an amino acid sequence of SEQ ID NO:23.

3. The Ebolavirus N-trimer mimic of claim 1 , wherein each peptide monomer comprises an amino acid sequence of SEQ ID NO:21.

4. A pharmaceutical composition comprising an Ebolavirus N-trimer mimic of claim 1 , and a pharmaceutically acceptable carrier.

5. A method of inhibiting Ebolavirus entry into a cell exposed to Ebolavirus , the methods comprising delivering an Ebolavirus N-trimer mimic of claim 1 to the cell exposed to Ebolavirus.

6. The method of claim 5 , wherein the cell is human.

Assignments (4)
CONFIRMATORY LICENSE Recorded Nov 4, 2022
From: UNIVERSITY OF UTAH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 061882/0868 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 10, 2018
From: UNIVERSITY OF UTAH
To: UNIVERSITY OF UTAH RESEARCH FOUNDATION
Reel/Frame 047731/0273 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 10, 2018
From: JACOBSEN, MICHAEL THOMAS; WEINSTOCK, MATTHEW T.; ECKERT, DEBRA MUIR; KAY, MICHAEL S.
To: UNIVERSITY OF UTAH
Reel/Frame 047731/0277 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 10, 2018
From: WELCH, BRETT D.
To: NAVIGEN, INC.
Reel/Frame 047731/0315 →
Continuity (2)
Provisional Application 62054835 · Sep 24, 2014
Related Publication 20170247418A1 · Aug 31, 2017